Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06613204 · ClinicalTrials.gov registry record · NA

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

A NA study of Caregiver Burden and Frontotemporal Dementia, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
640
Enrollment target
1
Study location

NCT06613204: Recruiting NA study of Caregiver Burden and Frontotemporal Dementia, sponsored by Oregon Health and Science University.

NCT06613204 is a NA study of Caregiver Burden and Frontotemporal Dementia that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 640 participants, above the 229-participant average among 41 other Caregiver Burden trials with a reported enrollment target (179% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06613204, a NA study of Caregiver Burden and Frontotemporal Dementia, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
640 participants
Enrollment target
1
Study location

Study Summary

The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.

Primary Outcome

Efficacy will be assessed by measuring pre/post changes on the RMBPC. The RMBPC is a 24-item caregiver report measure, 5-point Likert scale with higher scores on frequency indicate more upsetting behaviors Frequency range is 0 (never occurred) to 4 (daily or more often). Frequency score range is 0 to 96

Conditions Studied

Caregiver Burden Frontotemporal Dementia Corticobasal Syndrome Primary Progressive Aphasia(PPA)

Interventions

  • BEHAVIORAL STELLA-FTD Control
  • BEHAVIORAL STELLA-FTD Test

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 640 participants
Start Date 2025-06-23
Est. Completion 2029-06
Phase NA
Oregon Health and Science University

546 total trials

What NCT06613204 shows while recruiting

NCT06613204 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, above the 229-participant average among 41 other Caregiver Burden trials with a reported enrollment target (179% higher).

The record links to 4 conditions, with Caregiver Burden appearing as the primary indexed condition, and to 2 interventions - of which STELLA-FTD Control is the first listed.

NCT06613204 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT06613204 about?

NCT06613204 is a clinical study titled "STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners". The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent...

What is the current status of trial NCT06613204?

This trial is currently recruiting. It is a NA study. The enrollment target is 640 participants. The study started on 2025-06-23. Estimated completion is 2029-06.

What conditions does trial NCT06613204 study?

This clinical trial studies the following conditions: Caregiver Burden, Frontotemporal Dementia, Corticobasal Syndrome, Primary Progressive Aphasia(PPA).

What interventions are being tested in trial NCT06613204?

The interventions under investigation include: STELLA-FTD Control (BEHAVIORAL), STELLA-FTD Test (BEHAVIORAL).

Who is sponsoring clinical trial NCT06613204?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06613204 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Caregiver Burden

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06613204's enrollment target sits among peer trials

640 3rd of 41 higher than 39 of 41 other Caregiver Burden trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Caregiver Burden trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04339699 · 640 participants · NA

    NobleStitch EL STITCH Trial is a PFO Comparative Trial

  • NCT04979338 · 640 participants · Phase 3

    Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries

  • NCT05156398 · 640 participants · Phase 3

    Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  • NCT05930483 · 640 participants · NA

    Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06613204

Source: ClinicalTrials.gov NCT06613204, the US trial registry maintained by the National Library of Medicine. NCT06613204 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.